Download PDF
Thromb Haemost 1987; 57(02): 241
DOI: 10.1055/s-0038-1651108
Letters to the Editor
Schattauer GmbH Stuttgart

Antithrombotic Action of Hepatic Triglyceride Lipase - Fact or Fictaon

J Harenberg
Department of Internal Medicine, Medical School, University of Heidelberg, Bergheimer Straβe 58, 6900 Heidelberg F.R.G.
,
J Augustin
Department of Internal Medicine, Medical School, University of Heidelberg, Bergheimer Straβe 58, 6900 Heidelberg F.R.G.
› Author Affiliations
Further Information

Publication History

Received 29 December 1986

Accepted 04 February 1987

Publication Date:
28 June 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Barrowcliffe TW, Gray E, Merton RE, Dawes J, Jennings CC, Hubbard AR, Thomas DP. Anticoagulant activities of pentosan polysulphate (Hémoclar) due to release of hepatic triglyceride lipase (HTGL). Thromb Haemostas 1986; 56: 202-206
    PubMedGoogle Scholar
  • 2 Williams SP, Barrowcliffe TW. The effects of postheparin plasma lipases on anti-Xa clotting activity. Thromb Res 1985; 37: 371-377
    CrossrefPubMedGoogle Scholar
  • 3 De Swart C AM, Nijmeyer B, Andersson LO, Holmer E, Verschoor L, Bouma BN, Sixma J. Elimination of high-affinity heparin fraction and their anticoagulant and lipase activity. Blood 1984; 63: 836-842
    CrossrefPubMedGoogle Scholar
  • 4 Persson E, Nordenstrom J, Nilsson-Ehle P, Hagenfeld L. Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin. Eur J Clin Invest 1985; 15: 215-220
    CrossrefPubMedGoogle Scholar
  • 5 Harenberg J, Gnasso A, de Vries JX, Zimmermann R, Augustin J. Anticoagulant and lipolytic effects of a low molecular weight heparin fraction. Thromb Res 1985; 39: 683-692
    CrossrefPubMedGoogle Scholar
  • 6 Harenberg J, Augustin J. Lipolytic Activities of Low Molecular Weight Heparins. Thromb Res 1986; 42: 865-866
    CrossrefPubMedGoogle Scholar
  • 7 Augustin J, Greten H. The role of lipoprotein lipase, molecular properties and clinical relevance. In: Atherosclerosis Reviews. Vol. 5, pp. 91-124 Paoletti R, Gotto AM. (Eds).. Raven Press; New York: 1979
    Google Scholar
  • 8 Olivecrona T, Bengtsson G, Marklund SE, Lindahl U, Hook M. Heparin - lipoprotein lipase interactions. Fed Proceed 1977; 36: 60-64
    PubMedGoogle Scholar
  • 9 Gray E, Bengtsson-Olivecrona G, Olivecrona T, Barrowcliffe TW. The anti-Xa activity of human hepatic triglyceride lipase (HTGL). J Lab Clin Med. 1986 (in press)
    PubMedGoogle Scholar
  • 10 Cheng CF, Bensadoun A, Bersot T, Hsu J ST, Melford KH. Purification and Characterization of Human Lipoprotein Lipase and Hepatic Triglyceride Lipase. J Biol Chem 1985; 260: 10720-10727
    PubMedGoogle Scholar
  • 11 Harenberg J, Giese Ch, Knödler A, Zimmermann R. Antifactor Xa Clotting Method for Heparin and Low Molecular Weight Heparins. Ärztl Lab 1986; 32: 181-184
    PubMedGoogle Scholar
  • 12 Harenberg J. Modified antifactor Xa chromogenic substrate assay for heparin and low molecular weight heparin. Arztl Lab 1987; 33: 39-41
    PubMedGoogle Scholar